Related by context. All words. (Click for frequent words.) 68 PDE# inhibitors 68 anticancer therapeutics 68 OXIGON TM 68 kidney urologic 68 romazarit 67 Anavex #-# 67 mGluR2 NAM 67 adrenergic regulation 67 Vegenics 67 immunotherapeutic approaches 66 epilepsy Parkinson disease 66 thetreatment 66 ALK inhibitors 66 Curaxin 66 histone deacetylase HDAC 66 RhuDex TM 66 CB1 antagonists 66 novel therapeutic antibodies 66 PDE4 inhibitor 66 Ostabolin C TM 65 monoclonal antibody therapeutics 65 GPR# agonist 65 multitargeted 65 Squalamine 65 CYT# potent vascular disrupting 65 Monoclonal antibody 65 SuperAntibody 65 PI3K/Akt pathway inhibitor 65 engineered RAP peptides 65 rxRNA 65 therapeutic monoclonal antibodies 65 TÎ ² 4 65 Protein Kinase C 65 JAK inhibitors 65 cyclophilin inhibitors 65 Anticalins R 65 proteasome inhibitor 65 tubulin inhibitor 65 isoform selective 65 tiapamil 65 cholesteryl ester transfer 65 YONDELIS R 64 RhuDex R 64 therapeutic monoclonal antibody 64 AKT inhibitor 64 Prestara 64 HSP# inhibitors 64 Adenosine Therapeutics 64 histone deacetylase HDAC inhibitors 64 rheumatoid arthritis multiple sclerosis 64 Fc fusion protein 64 miRNA therapeutics 64 mGluR4 64 Archexin 64 constipation predominant irritable bowel 64 5 HT2A serotonin 64 MEK inhibitors 64 AMPK activators 64 Interferon beta 64 JAK2 inhibitor 64 acadesine 64 pathological hallmark 64 pathological hallmarks 64 Daclizumab 64 hypoxia activated prodrug 64 melanocortin receptor 64 SGLT inhibitors 64 GeneICE 64 highly selective endothelin 64 potently inhibit 64 SGLT Inhibitors 64 epigenetic therapies 64 IAP inhibitor 64 novel peptide 64 RNA antagonists 64 renin inhibitors 63 Onconase 63 humanized monoclonal antibodies 63 Oglemilast 63 dipeptidyl peptidase IV 63 oral antiplatelet agent 63 AE# vaccine 63 novel VDA molecule 63 immune modulating 63 small molecule agonists 63 DP VPA 63 selective androgen receptor modulators 63 treat chronic sinusitis 63 neuropathic pain spasticity 63 volociximab 63 relapsed acute myelogenous 63 Brussels THR 63 fusion enhancers 63 Factor VIIa 63 BCR ABL inhibitors 63 selective inhibition 63 small molecule thrombopoietin 63 Ampakine compounds 63 IAP inhibitors 63 adenosine A2A 63 psoriasis rheumatoid arthritis 63 Dyax phage display 63 progressive neurodegenerative disorder 63 diagnostic biomarker 63 IMiDs R 63 KuDOS 63 receptor tyrosine kinase inhibitor 63 cyclin dependent kinase inhibitor 63 antimitotic 63 progressive neurodegenerative 63 potent antiproliferative 63 GRN# 63 SinuNase ™ 63 BioFocus DPI Galapagos 63 JAK1 63 ZFP Therapeutics 63 diabetes irritable bowel 63 Insegia 63 PDE4 modulators 63 P#X# antagonist 63 transgenic mouse models 63 Novosom 63 novel peptides 63 NTDDS 63 biologic therapeutics 63 oral ghrelin agonist 63 IMiDs ® 63 novel immunotherapeutic 63 EHT AGN 63 endothelin antagonist 62 cardiometabolic disorders 62 FLT3 62 gamma secretase inhibitor 62 Pyridorin 62 Quark Biotech 62 non nucleoside HCV 62 Spiegelmer 62 Lixivaptan 62 myasthenia gravis Huntington 62 Panzem ® 62 ATL# [001] 62 antisense inhibitors 62 Symadex 62 EP #R 62 mGluR5 PAM 62 oncology infectious diseases 62 ATL/TV# 62 DGAT 62 STEDESA 62 novel immunotherapies 62 HepDirect R 62 INS# [001] 62 RhuDex ® 62 mTOR mammalian target 62 Adnectin 62 TLR9 agonists 62 novel anticancer 62 Ophthotech 62 pharmacological chaperone 62 Annamycin 62 anti amnesic 62 HepDirect prodrug 62 MediGene focuses 62 5 HT2C 62 Receptors GPCRs 62 5 HT2A inverse 62 metaglidasen 62 FTIs 62 delta gamma agonist 62 NB S# strontium malonate 62 oral immunomodulatory 62 Teplizumab 62 DCVax R 62 miRagen 62 epigenetic therapeutics 62 Aviptadil 62 prostanoid 62 immuno modulatory 62 thalidomide Thalomid 62 ghrelin antagonist 62 small molecule activators 62 antiapoptotic 62 cardio metabolic diseases 62 MAGE A3 ASCI 62 Smac mimetics 62 ibudilast 62 JAK3 inhibitor 62 erlotinib Tarceva 62 therapeutic peptide 62 tramiprosate Alzhemed TM 62 CB2 selective 62 selective modulator 62 humanized monoclonal 62 Panzem R 62 immunoregulation 62 AdhTAP 62 Camptothecin 62 mda 7 62 vascular disrupting agents 62 molecular chaperone regulation 62 ANTISENILIN ® 62 Etubics 62 AcryMed Incorporated 62 therapeutic mAbs 62 anti tumoral 62 ELND-#/AZD-# 62 selective receptor agonist 62 targeted radiotherapeutic 62 Wnt signaling pathway 62 LHRH receptor positive 62 Nanobody R 62 Deforolimus 62 protein tyrosine phosphatase 62 Immunotherapeutic 62 aMCI precursor 62 lymphomas leukemias 62 neuronal nicotinic receptors NNRs 62 nicotinic alpha 7 62 IMC #B 62 epothilone 62 Albugon 62 allosteric modulation 62 commercialize deforolimus 62 theranostic 61 PDGF receptor 61 novel anti infective 61 SERMs 61 Personalized Immunotherapy 61 Alzheimer disease cognitive impairment 61 JAK#/JAK# 61 PrevOnco 61 Uvidem 61 enhance ApoA 61 Aurora Kinase 61 diagnostic biomarkers 61 purinergic receptors P#X# 61 neurology immunology 61 cardio renal 61 Posiphen TM 61 CRTH2 61 androgen receptor antagonist 61 carbohydrate polymers 61 NuMimetic TM 61 #beta HSD1 61 DDP# 61 staphylococcal vaccine 61 CCR1 61 NPC 1C 61 PF # [002] 61 favorable pharmacokinetic 61 PNP inhibitor 61 tkRNAi technology 61 histone deacetylase inhibitors 61 anti CD3 61 RTP #i 61 XL# XL# 61 Tß4 61 sulfonylhydrazine class 61 Curaxin CBLC# 61 Selective Electrochemical Tumor Ablation 61 Parkinson disease Alzheimer disease 61 HQK 61 A3 adenosine receptor 61 vivo pharmacology 61 OTCBB NRGX biotechnology 61 Exelixis compounds 61 Aganocide ® 61 Evoltra ® 61 rheumatoid arthritis thrombocytopenia 61 neuro protective 61 Fibroblast Growth Factor Receptor 61 histone deacetylase inhibitor 61 Kevetrin ™ 61 orally administered inhibitor 61 oral Janus kinase 61 neuro inflammatory 61 XL# anticancer compounds 61 bardoxolone 61 VEGF inhibitors 61 pro angiogenic 61 HuMax TAC 61 Intellect Neurosciences 61 ARRY # 61 targeted antifolate 61 HCV protease inhibitors 61 Virulizin 61 EndoTAG TM 61 menstrual stem cell 61 mGluR4 PAM 61 gastro intestinal inflammation 61 PI3K/mTOR 61 Xanafide 61 nitric oxide donating prostaglandin 61 antisense inhibitor 61 candidate deforolimus 61 Maxy G# 61 prokinetic agent 61 sirtuin therapeutics 61 clinically validated targets 61 neuronal nicotinic receptor NNR 61 kallikrein 61 synthetic siRNA 61 neuro degenerative diseases 61 cathepsin K inhibitor 61 psoriasis Crohn disease 61 candidates Azedra TM 61 endophenotypes 61 Laevo 61 Antisense 61 alvespimycin 61 COX2 61 Apokyn 61 diarrhea predominant irritable 61 mitotic kinesins 61 Zavesca r 61 CCR2 61 accumulate preferentially 61 epothilones 61 INxin 61 RhuDex 61 immunotherapeutic vaccine 61 LymphoStat B belimumab 61 NS5b 61 GERD migraine headaches 61 novel immunomodulatory 61 VentiRx 61 5 HT4 61 selective immunoproteasome inhibitor 61 small molecule modulators 61 myeloproliferative disorders 61 RenaZorb TM 61 microtubule inhibitor 61 Neurodegenerative diseases 61 DGAT1 inhibitors 61 OTCBB PYTO 61 Epigenomics proprietary 61 ThermoDox ® clinical 61 Epothilones 61 Aquinox 61 Janus Kinase 61 MTP inhibitor 61 selective GR 61 Temsirolimus 61 alpha 2A adrenergic 61 activin receptor type 61 orally bioavailable mimics 61 TTR amyloidosis 61 relapsed leukemia 61 ViroChem Pharma Inc. 61 TRIOLEX HE# 61 autoimmune inflammatory 61 commercialize apixaban 61 siRNA therapeutics 61 tranilast 61 nitric oxide donating 61 SNT MC# 61 THR beta agonist 61 inverse agonist 61 Modrenal 61 ANTISENILIN R 61 liposomal delivery 61 FOLOTYN ® 61 Chemokine 61 lipid nanoparticle 61 BioNumerik 60 Saegis Pharmaceuticals 60 humanised antibody 60 vidofludimus 60 synthetic retinoid 60 anti CD3 monoclonal 60 COMT inhibitors 60 ARIKACE ™ 60 receptor modulators 60 Bayer HealthCare Onyx Pharmaceuticals 60 inflammation thrombosis oncology 60 alpha1 antitrypsin deficiency 60 amyloid imaging 60 targeting CD# 60 selective agonists 60 JAK inhibitor 60 AAG geldanamycin analog 60 CCR9 antagonist 60 Nanobody 60 HepDirect technology 60 systemic juvenile idiopathic 60 glucokinase activator 60 AcryMed technologies 60 myeloproliferative diseases 60 Kiadis 60 Modrenal R 60 CB2 receptor 60 ViroChem 60 seliciclib CYC# 60 monoclonal antibody MAb 60 Silodosin 60 proliferative diseases 60 NEUGENE R 60 novel peptide therapeutics 60 Cathepsin S 60 immunoregulatory 60 Tyzeka Sebivo 60 Myolimus 60 GPCR targets 60 beta amyloid peptides 60 incyclinide 60 unoprostone isopropyl 60 cytochrome P# enzymes 60 Psynova 60 anti CD# antibodies 60 p# inhibitor 60 Galenea 60 gemcitabine Gemzar ® 60 LNP formulations 60 delay bone metastases 60 sirtuin modulators 60 cognitive impairment associated 60 Ceflatonin R 60 ParAllele 60 SGLT2 inhibitors 60 psychiatric disorders ATI 60 Marqibo TM 60 INSPIRE Trial Phase III 60 inflammation metabolic disorders 60 Thalomid ® 60 taxane derivative 60 mGluR4 activation 60 microRNA therapeutics 60 Alfacell proprietary ribonuclease 60 nucleotide analogs 60 chronic thromboembolic pulmonary 60 Hedgehog antagonist 60 BHT DNA 60 Pimavanserin 60 personalized cellular immunotherapy 60 beta interferons 60 generation purine nucleoside 60 investigational compounds 60 HCV RNA polymerase 60 PDE# 60 humanised monoclonal antibody 60 Memryte 60 validate biomarkers 60 cytostatic 60 investigational humanized monoclonal antibody 60 Enkephalin 60 epilepsy neuropathic pain 60 immuno therapeutic 60 Colostrinin 60 Tesmilifene 60 syndrome carcinoid syndrome 60 endogenous ligands 60 Spiegelmer ® 60 YONDELIS 60 Cerashield ™ 60 Samjin 60 Erimos 60 Ii protein 60 prodrugs 60 MKC# MKC# PP 60 Valproic acid 60 Company Nasdaq RGDX 60 mertansine 60 myelofibrosis polycythemia vera 60 Safinamide 60 chemokine receptor 60 receptor inhibitor 60 HuMax 60 beta 1a 60 HuCNS SC ® 60 GRNOPC1 contains 60 optimal dosing regimens 60 TLR9 agonist 60 Glycosylation 60 schizophrenia CIAS 60 LEAD Therapeutics 60 Systemic lupus erythematosus SLE 60 Nektar proprietary 60 CureDM 60 ASONEP TM 60 Cloretazine 60 peptide therapeutics 60 GVAX ® 60 inflammatory autoimmune diseases 60 Receptos 60 Optiquel ™ 60 Inotek Pharmaceuticals Corporation 60 HGS# 60 Janus kinase 60 Nanobody ® 60 predictive biomarkers 60 siRNA therapeutic 60 HTS assay 60 CDP# 60 Teriflunomide 60 Ablaris Therapeutics 60 OvaRex ® MAb 60 mesenchymal cell 60 Alantos 60 biobetter 60 anticancer antiviral 60 DOS# 60 Nereus Pharmaceuticals 60 Sangamo ZFP technology 60 antiproliferative effects 60 M2 subunit 60 photodisinfection 60 ArQule Kinase Inhibitor Platform 60 pediatric acute lymphoblastic 60 TLR8 60 immuno inflammatory diseases 60 RECOTHROM R 60 selective serotonin 2C receptor 60 RELOVAIR ™ 60 Provectus Pharmaceuticals specializes 60 HepeX B 60 HepDirect 60 Amplimexon 60 XL# XL# XL# 60 CRAC channel 60 Pentad TM 60 Anidulafungin 60 KRAS oncogene 60 Prodarsan R 60 Litx 60 OXi# 60 non nucleoside inhibitor 60 G Protein Coupled 60 targeted biologic therapies 60 rheumatoid arthritis inflammatory bowel 60 intranasal insulin product 60 Ocrelizumab 60 entinostat 60 protein tyrosine phosphatases 60 ENMD # 60 demonstrated antitumor activity 60 reslizumab 60 tumor vascular disrupting 59 HIV integrase inhibitors 59 HCV polymerase 59 synthetic cannabinoid compounds 59 aurora kinase 59 5 HT4 receptor 59 gefitinib Iressa 59 PDE7 59 OXIGON 59 Myocet 59 Angiocept 59 neuroactive 59 CYP#A# CYP#D# 59 Potelligent Technology 59 anticoagulant reversing agent 59 MKC# MT 59 platform HDL Mimetic 59 Anticalin ® 59 VitiGam 59 HuLuc# 59 LymphoStat B TM 59 cicletanine 59 Zenapax 59 c myc gene 59 etanercept Enbrel 59 Nanobodies 59 TLR antagonists 59 molecular biomarkers 59 XL# XL# XL# XL# 59 antibody cytokine 59 Olaparib 59 RAF kinase 59 pharmacologic intervention 59 DNA methyltransferases 59 Aurora kinase inhibitor 59 treating neuropathic pain 59 ZFNs clinical trials 59 hereditary emphysema 59 HyACT 59 Miraxion Amarin lead 59 MicuRx 59 antiangiogenic agent 59 miRNA biomarkers 59 GSK3B 59 refractory metastatic 59 intracellular signaling pathways 59 optical biosensors 59 Onalta ™ 59 AVEO integrates proprietary 59 BXT # 59 PGL# 59 histone deacetylase HDAC inhibitor 59 Liprotamase 59 aptamer therapeutics 59 mediated inhibition 59 geldanamycin 59 dopamine D1 59 CRACM 59 Creabilis Therapeutics 59 catalytic antioxidant compounds 59 inhaled AAT 59 Guanilib 59 gastrointestinal stromal tumors GISTs 59 MOVIPREP R 59 agonists antagonists 59 5 HT2A 59 ospemifene 59 tramiprosate 59 antisense oligonucleotides 59 Homspera TM 59 ATL# [002] 59 vaccine GRNVAC1 59 biomarker identification 59 immunomodulatory properties 59 protein misfolding diseases 59 ASG 5ME 59 potent topoisomerase II 59 doxorubicin Transdrug R 59 PKC# 59 pralatrexate injection folate analogue 59 PKCi 59 acetylcholinesterase AChE 59 Endotis 59 alemtuzumab MS 59 estrogen receptor beta 59 NKT Therapeutics 59 immunomodulatory effects 59 neurotrophic 59 superparamagnetic iron oxide nanoparticles 59 NeuroSolutions 59 targeting PCSK9 59 Initiates Clinical 59 Solazed TM 59 evaluating satraplatin 59 orally bioavailable 59 SARMs 59 EnVivo Pharmaceuticals 59 KL4 Surfactant 59 Kosan dependence 59 BrachySil ™ 59 ERYtech 59 JAK3 59 Fumapharm 59 Sapacitabine 59 rheumatoid arthritis psoriasis 59 deCODE AF TM 59 PLX MS 59 Valdoxan 59 splice variants 59 Clusterin 59 Aerie Pharmaceuticals 59 multicenter Phase II 59 Brodmann Area 59 EnVivo 59 systemic sclerosis SSc 59 product platforms AZX# 59 Prodarsan ® 59 oxazolidinone 59 TGR5 59 validating biomarkers 59 immunotherapeutics 59 GPR# agonists 59 chimeric monoclonal antibody 59 FoldRx Pharmaceuticals Inc. 59 mGluR5 antagonist 59 Anticalin R 59 telomerase activators 59 developing TB4 59 LentiVector technology 59 Tasimelteon 59 DNA methyltransferase inhibitors 59 deCODE ProstateCancer TM 59 Tramiprosate ALZHEMED TM 59 neuropsychiatric diseases 59 drug conjugate 59 sodium glucose transporter 59 NNRs 59 Taligen Therapeutics 59 agomelatine 59 novel orally administered 59 IMiDs 59 Mipomersen 59 candidate custirsen 59 Phase IIb clinical trials 59 EndoTAG 59 mGluR2 positive 59 multiple sclerosis Crohn disease 59 Boniva ibandronate 59 oral PTH 59 GAD# 59 c myb 59 detect amyloid plaque 59 Cogane 59 protein tyrosine kinase 59 EGS# 59 Inc. Nasdaq NLTX 59 Aplidin 59 TRIOLEX ™ 59 triggers apoptosis programmed 59 protein tyrosine phosphatase 1B 59 identify protein biomarkers 59 commercialize becocalcidiol patented 59 outlicensing 59 PLX STROKE targeting 59 TBC# 59 inflammatory demyelinating 59 Pancreate 59 IgG1 monoclonal antibody 59 MolecularBreeding 59 Tovaxin ® 59 GSK '# 59 insulin sensitizers 59 HDL Selective Delipidation 59 Bellicum Pharmaceuticals Inc. 59 Canvaxin TM 59 Panzem R NCD 59 Scancell 59 Aposense Ltd. 59 genomic biomarker 59 cortisol synthesis 59 inhibit metastasis 59 gastrointestinal disorders ATI 59 adipose derived stem cell 59 XSSE OXGN 59 enGene 59 antitumoral 59 RNAi therapeutic targeting 59 dasatinib Sprycel 59 Prima BioMed 59 regorafenib 59 midstage clinical 59 adenoviral 59 Tykerb lapatinib 59 PSN# [002] 59 topical formulations 59 protein biochip 59 preclinical compounds 59 recombinant antibodies 59 DITPA 59 oral dihydropyrimidine dehydrogenase DPD 59 CCR3 59 Neogenix 59 peptibody 59 Spiegelmers 59 TRIOLEX HE# APOPTONE HE# 59 metabonomics 59 Solazed 59 mTOR inhibitors 59 Senexis 59 novel topoisomerase 59 ProLindac TM 59 peptidic 59 RNAi therapeutic targeting PCSK9 59 Vernalis plc 59 rolapitant 59 highly selective inhibitor 59 Alzheimer disease frontotemporal dementia 59 P#X# 59 HSP# inhibitor 59 PORxin TM 59 ReN# 59 Angiotensin converting enzyme ACE 59 PSN# [001] 59 commercialize pimavanserin 59 cMET 59 Revimmune TM 59 humanized therapeutic 59 ONCONASE R 59 immatics 59 vaccine GMK 59 LB# [003] 59 biologic pathways 59 antibody MAb 59 Cx# [002] 59 Systemic Delivery 59 Novolimus 59 underlying pathophysiology 59 Virulizin ® 59 muscarinic 59 Capsulution 59 thymidylate synthase TS 59 targeted radiotherapeutics 59 Smac mimetic 59 vaccines oncolytic virus 59 PIGF 59 endothelin receptor 58 Recombinant Human 58 atacicept 58 antisense drug 58 CYT# novel 58 neuroprotective properties 58 NurOwn 58 EnzymeRx 58 Fenretinide 58 sd rxRNA compounds 58 KSP inhibitor 58 selective S#P# receptor agonist 58 cMET inhibitor 58 engineered anticoagulant 58 neuropathologic 58 Sphingomab 58 bioactive lipids 58 novel histone deacetylase 58 genetic biomarkers 58 Intellikine 58 Akt inhibitor 58 neovascular diseases 58 Urocortin 2 58 Clofarabine 58 peptidomimetic 58 PDE4 58 peptide mimetics 58 investigational therapies 58 KIACTA ™ 58 Cutanea 58 Apoptone 58 MEK inhibitor 58 multiple sclerosis psoriasis 58 Dynogen 58 autoimmune uveitis 58 stapled peptides 58 Presents Preclinical 58 Rescula 58 CDK inhibitor 58 prostone 58 Synuclein 58 fibrotic disorders 58 www.pranabio.com 58 EVIZON TM squalamine lactate 58 idiopathic thrombocytopenic purpura 58 engineered proteases 58 selective estrogen receptor modulator 58 lixivaptan 58 OvaRex R 58 NOX E# 58 Locus Pharmaceuticals 58 proprietary biomaterials 58 polycythemia vera PV 58 selectively inhibited 58 metabolite profiling 58 leukotriene pathway 58 AC Immune 58 Crohn disease rheumatoid arthritis 58 formerly LymphoStat B 58 OncoGel 58 autoimmune encephalitis 58 telomerase therapeutic 58 immune modulatory 58 Antiangiogenic 58 vascular disrupting agent 58 Junovan TM 58 SYN# 58 DiObex 58 VIPR2 58 novel emulsion formulation 58 EGFR HER 58 neuronal dysfunction 58 Pagoclone 58 Virdante 58 Lu AA# 58 Parathyroid hormone 58 Lenocta 58 M# rationally 58 LEVADEX ™ 58 FGFR 58 Lewy bodies DLB 58 sphingolipid 58 Initiates Clinical Trial 58 sirtuin activators 58 Noscira 58 peptide peptide mimetic 58 PPARγ 58 immunomodulation 58 fostamatinib 58 transgenic mouse model 58 Triapine 58 Protalex Inc. 58 Familial Adenomatous Polyposis FAP 58 IMiDs ® compound 58 Syndax Pharmaceuticals Inc. 58 NexGenix 58 TLR Therapeutics 58 selective antagonist 58 subtype selective 58 renal fibrosis 58 renin inhibitor 58 Captisol enabled 58 Acetylon 58 novel antibody therapeutics 58 SGLT 2 58 beta amyloid peptide 58 Syntonix 58 oral salmon calcitonin 58 Combivir Kivexa 58 sargramostim 58 acetonide FA 58 infectious autoimmune 58 myeloproliferative neoplasms 58 elotuzumab 58 pathophysiological effects 58 SIRT1 activators 58 certain protein tyrosine 58 immune modulators 58 novel radiopharmaceuticals 58 PhaseBio 58 Adentri 58 VaxImmune 58 SonoLysis 58 multi kinase inhibitor 58 molecularly targeted 58 neurokinin 1 58 novel antiviral therapeutics 58 potent cytotoxic 58 anti PlGF 58 vivo validation 58 Peptide YY 58 TRAIL receptor antibodies 58 Pathway Inhibitor 58 Pim kinases 58 VEGF receptor 58 LX# LX# LX# 58 lupus multiple sclerosis 58 TRACON Pharmaceuticals 58 immunotoxin 58 midkine 58 Arisaph 58 novel oral anticoagulant 58 BiolineRX 58 small molecule defensin 58 ocular inflammatory 58 SILENOR 58 neuropathic pain metabolic diseases 58 FivePrime Therapeutics 58 cellular immunotherapy 58 Preclinical studies suggest 58 Triapine R 58 pan HDAC inhibitor 58 Nautilus Biotech 58 Aganocide TM 58 signal transduction inhibitor 58 AFFiRiS 58 dyslipidemia hypertension diabetes 58 uricase 58 deacetylase 58 PrevOnco ™ 58 ACTCellerate 58 Ceragenin ™ 58 anti fibrotic 58 TOCOSOL 58 dimebon latrepirdine 58 rasagiline tablets 58 Locked Nucleic Acid LNA 58 Agios Pharmaceuticals 58 Infectech 58 M1 muscarinic 58 theranostics 58 amyloid beta plaques 58 Factor VEGF 58 histamine dihydrochloride 58 MELAS 58 eligen 58 Fleximer 58 histone deacetylase 58 dirucotide MBP# 58 galectin 58 OncoVex 58 selective kinase inhibitor 58 VIBEX MTX 58 Adherex Technologies 58 HuCAL R 58 citicoline 58 DNA methylation biomarkers 58 Olmesartan 58 oral nucleoside analogue 58 Zemiva TM 58 vinca alkaloid 58 vivo preclinical 58 peptide receptor 58 class mGluR5 inhibitor 58 maturation inhibition 58 Cyclosert TM 58 Milnacipran 58 anti secretory 58 mTOR inhibition 58 Enzastaurin 58 Pitavastatin 58 LAS# [002] 58 TRAIL induced apoptosis 58 HepaMate ™ 58 immunomodulating 58 delipidation 58 R roscovitine 58 HDACi 58 EGFR TKIs 58 Azedra TM 58 DeveloGen 58 Omacetaxine 58 CTLA4 Ig 58 ALS #-# 58 peripherally acting 58 myeloproliferative 58 molecular imaging radiopharmaceutical 58 gallium containing